OCT 21·SEC EDGARLow
Tamari Shahar sold $988K of GLBE
Tamari Shahar (COO) sold 24,999 shares of Global-E Online Ltd. (GLBE) at $39.54 ($0.99M total) on 2026-10-19 under a Rule 10b5-1 trading plan.
StockNASDAQ · US · USDConsumer Cyclical · Internet Retail
$GLBE
Global-E Online Ltd.
AlphAI earnings readQ2 FY2026 · AUG 12Global-e Achieves Significant GMV, Revenue and Profit Expansion in the Second Quarter of 2026, Raises Outlook for the YearVerdict: strongRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $GLBEvia TradingView
AI sentiment · 7d9 articles
- Bullish
- 9
- Neutral
- 0
- Bearish
- 0
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $7.2M 14 txs
Schlachet Amir5× · $2.0M
10b5-1 share of filings100%
Top stories · $GLBEMore →
OCT 20·SEC EDGAR
Schlachet Amir sold $976K of GLBE
Schlachet Amir (CEO) sold 24,999 shares of Global-E Online Ltd. (GLBE) at an average of $39.04 ($38.90–$40.55, $0.98M total) across 3 trades on 2026-10-16 under a Rule 10b5-1 trading plan.
OCT 19·tradingview.com
Global-E Online Ltd. Stock 12‑Month Price Target Raised to $50.86, Implies 31% Upside
Analysts raised Global-E Online Ltd.'s average price target to $50.86, up from $50.57, with a range of $45 to $64. This implies a 31% upside from the Oct. 16 closing price. The consensus rating remains 'Buy' among 16 analysts.
GLBE sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 9 news stories mentioning GLBE (Global-E Online Ltd.). Coverage has skewed bullish: 9 bullish, 0 neutral, and 0 bearish.
Recent GLBE coverage spans financial news and insider activity.
In the last 30 days, GLBE insiders filed 14 SEC Form 4 transactions — no purchases and 14 sales ($7.2M). The most active reporter was Schlachet Amir, CEO, with 5 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
What's driving GLBE
Insider sale may signal reduced confidence or simply portfolio rebalancing.
The insider sale may be interpreted as a lack of confidence, creating modest downside pressure.
The upward revision suggests bullish sentiment and may attract buying pressure.
The insider sale may signal confidence concerns, prompting short-term price pressure.
Overweight rating could drive buying interest.
AlphAI scores every news story that mentions GLBE with an AI model for sentiment and relevance, and aggregates insider trades from Global-E Online Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $GLBE
Score
Tamari Shahar sold $988K of GLBE
Tamari Shahar (COO) sold 24,999 shares of Global-E Online Ltd. (GLBE) at $39.54 ($0.99M total) on 2026-10-19 under a Rule 10b5-1 trading plan.
1 min readSchlachet Amir sold $976K of GLBE
Schlachet Amir (CEO) sold 24,999 shares of Global-E Online Ltd. (GLBE) at an average of $39.04 ($38.90–$40.55, $0.98M total) across 3 trades on 2026-10-16 under a Rule 10b5-1 trading plan.
1 min read
Global-E Online Ltd. Stock 12‑Month Price Target Raised to $50.86, Implies 31% Upside
Analysts raised Global-E Online Ltd.'s average price target to $50.86, up from $50.57, with a range of $45 to $64. This implies a 31% upside from the Oct. 16 closing price. The consensus rating remains 'Buy' among 16 analysts.
1 min readDebbi Nir sold $581K of GLBE
Debbi Nir (President) sold 14,582 shares of Global-E Online Ltd. (GLBE) at an average of $39.81 ($38.48–$40.18, $0.58M total) across 3 trades on 2026-10-15 under a Rule 10b5-1 trading plan.
1 min readThis Intel Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
Analysts upgraded several companies: JP Morgan upgraded Intel (INTC) to Neutral with an $85 target, Morgan Stanley upgraded Boyd Gaming (BYD) to Overweight with an $83 target, B of A upgraded Dow (DOW) to Neutral with a $31 target, Morgan Stanley upgraded Global-E (GLBE) to Overweight with a $50 target, and Bernstein upgraded Datadog (DDOG) to Outperform with a $350 target.
2 min read
Here are Monday's biggest analyst calls: SpaceX, Nvidia, Apple, CoreWeave, Amazon, Meta, Eli Lilly & more
Analysts made several calls: Goldman upgraded CoreWeave to Buy with a $106 target, Morgan Stanley named Amazon a top pick with a $350 target, and raised Meta's target to $820. Bernstein upgraded Datadog, JPMorgan upgraded Intel to Neutral, and Bank of America reiterated Apple as Buy. Other notable upgrades include Boyd Gaming, Dow, Exxon, Global-E Online, Nvidia, Global Payments, Eli Lilly, and Match.
3 min readMicrosoft To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Monday - Microsoft (NASDAQ:MSFT)
Analysts updated price targets for several companies. Bernstein raised Microsoft's target to $662, maintaining an Outperform rating. Morgan Stanley increased Global-E Online's target to $50 and upgraded it to Overweight. Other notable changes include Truist Financial, Annexon, Ameriprise Financial, Lyft, A O Smith, Hudson Pacific Properties, Boyd Gaming, and Veradermics.
2 min readMorgan Stanley upgrades Global-E Online stock rating on growth outlook
Morgan Stanley upgraded Global-E Online (GLBE) to Overweight, raising its price target to $50. The firm cited mid-teens same-store-sales growth and improved net dollar retention estimates. GLBE reported Q2 GMV of $2.09B, revenue of $299M, and adjusted EBITDA of $62.4M, all exceeding estimates. Multiple analysts have raised price targets and reiterated positive ratings.
1 min readGlobal-e, Immersion, Talos, Liquidia, Prothena Insider Shake-Up
Insiders at five companies made notable trades. Global-e's CEO and president sold shares worth $978,363 and $585,758, respectively. Immersion's director bought 41,000 shares for $292,799. Talos Energy's additional representative sold 480,000 shares for $8,136,000. Liquidia's director sold 235,477 shares for $6,386,136. Prothena's significant shareholder bought 315,000 shares for $2,677,400.
2 min readRegenerative Medical Technology Group: RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks
Regenerative Medical Technology Group (RMTG) expanded its ISSCA division's Online Academy with ten new curriculum tracks in regenerative medicine. The move aims to diversify revenue and reach more physicians globally, according to the company. RMTG operates in over 30 countries and trades on the OTC market.
2 min read